189 related articles for article (PubMed ID: 6982931)
1. Biosynthesis and glycosylation of the invariant chain associated with HLA-DR antigens.
Machamer CE; Cresswell P
J Immunol; 1982 Dec; 129(6):2564-9. PubMed ID: 6982931
[TBL] [Abstract][Full Text] [Related]
2. Invariant chain associates with HLA class II antigens via its extracytoplasmic region.
Marks MS; Cresswell P
J Immunol; 1986 Apr; 136(7):2519-25. PubMed ID: 3512715
[TBL] [Abstract][Full Text] [Related]
3. Invariant chain influences post-translational processing of HLA-DR molecules.
Schaiff WT; Hruska KA; Bono C; Shuman S; Schwartz BD
J Immunol; 1991 Jul; 147(2):603-8. PubMed ID: 2071896
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the biosynthesis of HLA-DR glycoproteins in human malignant melanoma cell lines.
Lloyd KO; Ng J; Dippold WG
J Immunol; 1981 Jun; 126(6):2408-13. PubMed ID: 6785352
[TBL] [Abstract][Full Text] [Related]
5. HLA-DR antigens of autologous melanoma and B lymphoblastoid cell lines: differences in glycosylation but not protein structure.
Alexander S; Hubbard SC; Strominger JL
J Immunol; 1984 Jul; 133(1):315-20. PubMed ID: 6609984
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the oligosaccharides on the HLA-DR and DC1 B cell antigens.
Shackelford DA; Strominger JL
J Immunol; 1983 Jan; 130(1):274-82. PubMed ID: 6600184
[TBL] [Abstract][Full Text] [Related]
7. Assembly and transport properties of invariant chain trimers and HLA-DR-invariant chain complexes.
Lamb CA; Cresswell P
J Immunol; 1992 Jun; 148(11):3478-82. PubMed ID: 1588042
[TBL] [Abstract][Full Text] [Related]
8. Variation in HLA-DM expression influences conversion of MHC class II alpha beta:class II-associated invariant chain peptide complexes to mature peptide-bound class II alpha beta dimers in a normal B cell line.
Ramachandra L; Kovats S; Eastman S; Rudensky AY
J Immunol; 1996 Mar; 156(6):2196 - 2204. PubMed ID: 8690909
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of Ii synthesis, processing, and turnover in n-butyrate-treated Burkitt's lymphoma cell lines which express or do not express class II antigens and in hairy leukemic cells.
Spiro RC; Sairenji T; Humphreys RE
J Immunol; 1985 May; 134(5):3539-49. PubMed ID: 3856614
[TBL] [Abstract][Full Text] [Related]
10. Structure, biosynthesis, and polymorphism of chicken MHC class II (B-L) antigens and associated molecules.
Guillemot F; Turmel P; Charron D; Le Douarin N; Auffray C
J Immunol; 1986 Aug; 137(4):1251-7. PubMed ID: 2942601
[TBL] [Abstract][Full Text] [Related]
11. Rapid nonlysosomal degradation of assembled HLA class II glycoproteins incorporating a mutant DR alpha-chain.
Koppelman B; Cresswell P
J Immunol; 1990 Oct; 145(8):2730-6. PubMed ID: 2212658
[TBL] [Abstract][Full Text] [Related]
12. [HLA-DR antigens: cellular expression and molecular structure].
Charron DJ
Ann Immunol (Paris); 1982; 133D(2):155-69. PubMed ID: 6187269
[TBL] [Abstract][Full Text] [Related]
13. Monensin prevents terminal glycosylation of the N- and O-linked oligosaccharides of the HLA-DR-associated invariant chain and inhibits its dissociation from the alpha-beta chain complex.
Machamer CE; Cresswell P
Proc Natl Acad Sci U S A; 1984 Mar; 81(5):1287-91. PubMed ID: 6608726
[TBL] [Abstract][Full Text] [Related]
14. The role of the Ia-invariant chain complex in the posttranslational processing and transport of Ia and invariant chain glycoproteins.
Simonis S; Miller J; Cullen SE
J Immunol; 1989 Dec; 143(11):3619-25. PubMed ID: 2584710
[TBL] [Abstract][Full Text] [Related]
15. Characterization of HLA-D-region antigens by two-dimensional gel electrophoresis. Molecular-genotyping.
Charron DJ; McDevitt HO
J Exp Med; 1980 Aug; 152(2 Pt 2):18s-36s. PubMed ID: 6931876
[TBL] [Abstract][Full Text] [Related]
16. Immunologically discrete conformation isomers of I-A locus-equivalent class II molecules detected in Lewis rats.
Reske K; Weitzel R
Eur J Immunol; 1985 Dec; 15(12):1229-39. PubMed ID: 3878790
[TBL] [Abstract][Full Text] [Related]
17. A defect in the regulation of major histocompatibility complex class II gene expression in human HLA-DR negative lymphocytes from patients with combined immunodeficiency syndrome.
Lisowska-Grospierre B; Charron DJ; de Préval C; Durandy A; Griscelli C; Mach B
J Clin Invest; 1985 Jul; 76(1):381-5. PubMed ID: 3860509
[TBL] [Abstract][Full Text] [Related]
18. Analysis of DR-like molecules on a marmoset Epstein-Barr virus-induced cell line using a monomorphic anti-human HLA-DR monoclonal antibody.
Teillaud JL; Charron D; Goujet-Zalc C; Mahouy G
Eur J Immunol; 1982 May; 12(5):446-8. PubMed ID: 6284521
[TBL] [Abstract][Full Text] [Related]
19. Murine Ia-associated invariant chain's processing to complex oligosaccharide forms and its dissociation from the I-Ak complex.
Holt GD; Swiedler SJ; Freed JH; Hart GW
J Immunol; 1985 Jul; 135(1):399-407. PubMed ID: 3873494
[TBL] [Abstract][Full Text] [Related]
20. Acquisition of peptides by MHC class II polypeptides in the absence of the invariant chain.
Hitzel C; van Endert P; Koch N
J Immunol; 1995 Feb; 154(3):1048-56. PubMed ID: 7822782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
